Latest filing published 23 Dec 2011 for Spectrum Pharmaceuticals INC, €979k.
Insider track record
No signal scores available.
James Shields: trading record in brief
James Shields discloses dealings in Spectrum Pharmaceuticals Inc to SEC (Form 4). The record holds 4 filings, for trades running from 3 January 2011 to 23 December 2011.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 23 December 2011, the filings show a share grant worth €979k in Spectrum Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James Shields
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 86,500 shares@ US$14.77Common Stock, $0.001 par valueSEC:0001209191-11-063071:0
- 36,719 shares@ US$14.77Common Stock, $0.001 par valueSEC:0001209191-11-063071:1
- 10,000 shares0Common Stock, $0.001 par valueSEC:0001209191-11-058826:0
- 20,000 shares0Common Stock $.001 Par ValueSEC:0001209191-11-000503:0
4 of 4 declarations